Antares Vision S.p.A. designs, manufactures, installs, and maintains inspection and track and trace systems for the security and traceability/ e-pedigree in the pharmaceutical sector.
Excellent balance sheet with moderate growth potential.
Share Price & News
How has Antares Vision's share price performed over time and what events caused price changes?
Latest Share Price and Events
7 Day Return
IT Healthcare Services
1 Year Return
IT Healthcare Services
Return vs Industry: Insufficient data to determine how AV performed against the Italian Healthcare Services industry.
Return vs Market: Insufficient data to determine how AV performed against the Italian Market.
Share holder returns
Price Volatility Vs. Market
How volatile is Antares Vision's share price compared to the market and industry in the last 5 years?
Simply Wall St News
Is Antares Vision undervalued based on future cash flows and its price relative to the stock market?
Intrinsic Value Based on Future Cash Flows
Undervalued: AV (€9.9) is trading above our estimate of fair value (€8.07)
Significantly Undervalued: AV is trading above our estimate of fair value.
Price Based on Earnings
PE vs Industry: Insufficient data to calculate AV's PE Ratio to determine if it is good value compared to the Healthcare Services industry average.
PE vs Market: Insufficient data to calculate AV's PE Ratio to determine if it is good value compared to the Italian market.
Price Based on Expected Growth
Low PEG Ratio: Insufficient data to calculate AV's PEG Ratio to determine if it is good value.
Price Based on Value of Assets
PB vs Industry: Insufficient data to calculate AV's PB Ratio to determine if it is good value.
How is Antares Vision expected to perform in the next 1 to 3 years based on estimates from 1 analyst?
Forecasted annual earnings growth
Earnings and Revenue Growth Estimates
Future Annual Growth Analysis
Earnings vs Savings Rate: AV's forecast earnings growth (18.6% per year) is above the savings rate (2.9%).
Earnings vs Market: AV's earnings (18.6% per year) are forecast to grow faster than the Italian market (8.8% per year).
High Growth Earnings: AV's earnings are forecast to grow, but not significantly.
Revenue vs Market: AV's revenue (19.4% per year) is forecast to grow faster than the Italian market (3.2% per year).
High Growth Revenue: AV's revenue (19.4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Estimates
Future Return on Equity
High Future ROE: AV's Return on Equity is forecast to be low in 3 years time (17.8%).
How has Antares Vision performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: AV's earnings have grown significantly by 32% per year over the past 5 years.
Accelerating Growth: AV's earnings growth over the past year (20.9%) is below its 5-year average (32% per year).
Earnings vs Industry: AV earnings growth over the past year (20.9%) exceeded the Healthcare Services industry 8%.
Return on Equity
High ROE: AV's Return on Equity (18.2%) is considered low.
Return on Assets
ROA vs Industry: AV has a higher Return on Assets than the Healthcare Services industry average last year.
Return on Capital Employed
ROCE Improving: AV's Return on Capital Employed has declined over the past 3 years.
How is Antares Vision's financial position?
Financial Position Analysis
Short Term Liabilities: AV's short term assets (€179.0M) exceeds its short term liabilities (€39.9M)
Long Term Liabilities: AV's short term assets (179.0M) exceeds its long term liabilities (22.8M)
Debt to Equity History and Analysis
Debt Level: AV's debt to equity ratio (20.4%) is considered satisfactory
Reducing Debt: Insufficient data to determine if AV's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: AV's debt is well covered by operating cash flow (46.4%).
Interest Coverage: AV's interest payments on its debt are well covered by EBIT (74.2x coverage).
Inventory Level: AV has a low level of unsold assets or inventory.
Debt Coverage by Assets: AV's debt is covered by short term assets (assets are 6.773330x debt).
What is Antares Vision's current dividend yield, its reliability and sustainability?
Expected Dividend Yield
Dividend Yield vs Market
Current dividend yield vs market & industry
Dividend Yield and Payments Analysis
Notable Dividend: Unable to evaluate AV's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate AV's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if AV's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if AV's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of AV's dividend in 3 years as they are not forecast to pay a notable one for the Italian market.
What is the CEO of Antares Vision's salary, the management and board of directors tenure and is there insider trading?
Emidio Zorzella 0
Mr. Emidio Zorzella is the Co-Founder of Antares Vision Srl. in 2007 and serves as its Chief Executive Officer and Managing Director.
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
CEO & Co-Founder
- Tenure: 0yrs
- Tenure: 0yrs
Antares Vision S.p.A.'s company bio, employee growth, exchange listings and data sources
- Name: Antares Vision S.p.A.
- Ticker: AV
- Exchange: BIT
- Founded: 2007
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: €573.518m
- Shares outstanding: 57.93m
- Website: https://www.antaresvision.com
- Antares Vision S.p.A.
- Via Del Ferro, 16
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|AV||BIT (Borsa Italiana)||Yes||Share Capital||IT||EUR||Apr 2019|
Antares Vision S.p.A. designs, manufactures, installs, and maintains inspection and track and trace systems for the security and traceability/ e-pedigree in the pharmaceutical sector. It provides track and ...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2019/10/14 01:04|
|End of Day Share Price||2019/10/11 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.